Tag: Prescription Drugs
Osteonecrosis of Jaw Risk Highest for IV Bisphosphonate Use
High risk for zoledronate, denosumab mainly in prevention of skeletal-related events
Intravenous Cyclosporine Doesn’t Improve STEMI Outcomes
For patients undergoing PCI, cyclosporine doesn't prevent adverse left ventricular remodeling at 1 year
Lower Risk of Dabigatran-Tied Bleeding With Gastroprotection
Concomitant use of gastroprotective agents linked to lower risk of gastrointestinal bleeding
Patient Satisfaction Up for Dulaglutide Treatment in T2DM
Improvement in patient satisfaction, decrease in perceived frequency of hyperglycemia
Daratumumab Monotherapy Promising for Multiple Myeloma
Findings in a phase 1-2 study of patients with relapsed myeloma or relapsed/refractory myeloma
Periop Bridging Unnecessary for Most A-Fib Patients on Warfarin
Arterial thromboembolism risk doesn't appear to rise without additional drug treatment
FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs
All biotech drugs to carry a four-letter code to distinguish brand name, generic versions
Worse Outcomes for Children With Delay in Epinephrine
Findings among cohort of children with in-hospital cardiac arrest with initial nonshockable rhythm
Antiviral Rx May Help Prevent Ebola, Small Study Suggests
Health care workers on antiviral regimen didn't develop disease after exposure
No Cognitive Benefits Seen for Elderly Who Stop HTN Rx
Prior research suggests lower BP increases risk for cognitive decline in elderly
